Essentials: Prescribing Naloxone to Patients for Overdose Reversal
This lecture is designed to provide the learner with brief history of the events in the late 1990s that resulted in today's opioid epidemic, discuss the epidemiology of opioid overdose and the neurobiology of overdose. Risk factors for overdose, the use of naloxone for overdose, and state laws regarding prescribing naloxone will be discussed.
Goals and Objectives:
At the conclusion of this activity participants should be able to:
- Discuss how the opioid prescribing epidemic is associated with the overdose epidemic
- Discuss opioid overdose risk factors
- Describe the basic pharmacology of naloxone
- Describe studies demonstrating the efficacy of naloxone in bystander overdose
- Name the four different forms of naloxone available for bystander reversal of overdose and discuss to prescribe it
Julie Kmiec, DO, FAOAAM (Moderator)
AOAAM Past President
Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Assistant Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program, Bridge Clinic, and is the founding medical director of the Narcotic Addiction Treatment Program’s Buprenorphine Clinic at WPIC. Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the President of the American Osteopathic Academy of Addiction Medicine.
|Access Date||Quiz Result||Score||Actions|